Skip to main content
Screener/Healthcare/Biotechnology

MIRM — Mirum Pharmaceuticals, Inc.

NASDAQ
$100.95+6.96 (+7.40%)
Mid CapHealthcareLow Beta
$54.75
$130.00
$94.25
$100.95
EPS (TTM)$-13.62
P/E Ratio-201.97
Dividend Yield—
Market Cap$6.36B
Volume594K
Prev Close$94.11
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$790.2M$-13.43——
Q4 '25$148.9M-$5.7M$-0.1281.0%-3.8%
Q3 '25$133.0M$2.9M$0.0580.8%2.2%
Q2 '25$127.8M-$5.9M$-0.1281.7%-4.6%
Q1 '25$111.6M-$14.7M$-0.3079.4%-13.2%
Q4 '24$99.4M-$23.8M$-0.4977.1%-23.9%
Q3 '24$90.4M-$14.2M$-0.3077.0%-15.8%
Q2 '24$77.9M-$24.6M$-0.5274.0%-31.6%
Get Your Daily Market Recap